The microarray module 2 contains gene BIRC5, which previously found to be strongly overexpressed in neuroblastoma tumor samples and correlate to a poor prognosis, which could be a potential therapeutic target [9, 18]. This evidence concerns the gene BIRC5 and neuroblastoma.